Leukotrienes in ulcerative colitis: Results of a multicenter trial of a leukotriene biosynthesis inhibitor, MK-591

Gastroenterology

Volumn 112, Issue 3, 1997, Pages 725-732

  Roberts, W G ^a   Simon, T J ^a   Berlin, R G ^a   Haggitt, R C ^a   Snyder, E S ^a   Stenson, W F ^a   Hanauer, S B ^a   Reagan, J E ^a   Cagliola, A ^a   Tanaka, W K ^a   Simon, S ^a   Berger, M L ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 (2 QUINOLINYLMETHOXY) 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; LEUKOTRIENE B4; LIPOXYGENASE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DISEASE ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RECTUM; REMISSION; RESPIRATORY TRACT INFECTION; SINUSITIS; ULCERATIVE COLITIS; VERTIGO; WEIGHT REDUCTION;

EID: 0031047277     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.1997.v112.pm9041233     Document Type: Article

References (25)